Polysomnography Devices Market Analysis

  • Report ID: 5500
  • Published Date: Nov 26, 2025
  • Report Format: PDF, PPT

Polysomnography Devices Market Segmentation:

Type Segment Analysis

The fixed segment in the polysomnography devices market is estimated to gain a robust revenue share of 64% in the coming years owing to the growing burden of obstructive sleep apnea (OSA). For instance, it is estimated that more than 930 million persons worldwide suffer from mild to severe obstructive sleep apnea (OSA). It is a widespread chronic sleep-related breathing disorder characterized by recurring bouts of hypopnea and apnea and is known to be one of the most prevalent co-morbidities among individuals with interstitial lung disease (ILD). Moreover, it has been reported that the prevalence of OSA in ILD ranges from around 15–85%, while in healthy adults, it is over 3%. Interstitial lung diseases are a diverse set of conditions that may lead to increased BMI which is a significant risk factor for OSA.

To diagnose OSA, polysomnography (PSG) or overnight sleep study, is necessary which may necessitate the use of fixed polysomnography equipment for sleep staging in individuals. These devices are often used in sleep laboratories to detect conditions including OSA through the use of multiple sensors. Particularly, they allow medical professionals to observe abnormalities during an entire night’s sleep and tailor the treatment procedures accordingly.

Additionally, for a thorough examination of sleep, the portable polysomnograph records eight electrophysiological signals to provide more accurate readings when working in a laboratory. It is used by numerous clinics and hospitals since they can be customized, and are available at extremely affordable prices.

Application Segment Analysis

The diagnostic laboratories segment in the polysomnography devices market is set to garner a notable share shortly. A sleep diagnostic lab specializes in the diagnosis of several sleep-related conditions whereby overnight sleep behavior and pattern is monitored which is required for early diagnosis and treatment. These sleep labs have a bedroom-style configuration with sensors that are affixed to the patient's head using a thin layer of adhesive that aids in the examination of heart rate, respiration patterns, brain activity, blood oxygen level, eye and leg movements, and heart rate.

Furthermore, in homecare settings, polysomnography devices are being used for easy sleep investigations as they are affordable and easy to use. Besides this, these gadgets can be utilized for research on sleep problems in medical facilities or hospitals under the guidance of skilled specialists to prevent negative health effects.

Our in-depth analysis of the global polysomnography devices market includes the following segments:

Type

  • Fixed
  • Portable

Voltage

  • >10
  • >16
  • >32
  • >56

Application

  • Hospitals
  • Diagnostic Laboratories
  • Homecare Settings

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of polysomnography devices is assessed at USD 313.78 million.

The global polysomnography devices market size surpassed USD 301.57 million in 2025 and is projected to witness a CAGR of over 4.5%, crossing USD 468.33 million revenue by 2035.

By 2035, North America is forecast to capture a 46% share of the polysomnography devices market, impelled by rising mergers and acquisitions that expand product availability.

Key players in the market include Nox Medical, BMC Medical, CleveMed, Recorders & Medicare Systems, Medicom MTD, Compumedics, Dr. Langer Medical, Neurovirtual, Shanghai NCC Medica, Contec Medical Systems., CleveMed, SOMNOmedics GmbH, Cidelec, ResMed, Vyaire Medical, Natus Medical, Koninklijke Philips, Bittium Biosignals Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos